stars 1 stars 2 stars 3

NovogeneAIT Genomics, headquartered in Singapore, is a premier provider of multi-omics services and solutions. Established in 2016 through a strategic joint venture between Novogene and AITbiotech, we have grown to be one of the largest NGS service providers in Southeast Asia. Our unwavering commitment to delivering high-quality, efficient, and cost-effective omics solutions has propelled us to the forefront of genomic research. NovogeneAIT Genomics offers an extensive range of multi-omics services, including genomics, transcriptomics, single-cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our cutting-edge sequencing center in Singapore, we are dedicated to advancing scientific research by providing superior data quality. For more information, visit www.novogene.com/amea-en/

NovogeneAIT Questions

The NovogeneAIT annual revenue was $379.5 million in 2026.

Justin Lee is the CEO of NovogeneAIT.

54 people are employed at NovogeneAIT.

The NAICS codes for NovogeneAIT are [453210, 4532, 453, 45321, 45].

The SIC codes for NovogeneAIT are [59, 594].

Top NovogeneAIT Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users